Meet Our Clinical Collaborators

The collective writings of these respected leaders provide deep medical perspectives and guidance to the management team while‘supporting the tenets of NuView Life Science’s goals.

LEONARD G. GOMELLA, MD, FACS

Clinical Collaborator

Dr. Leonard Gomella is the Bernard W. Godwin, Jr. Professor of Prostate Cancer and Chairman of the Department of Urology at Jefferson Medical College, Senior Director Clinical Affairs, Sidney Kimmel Cancer Center, Urology Clinical Service Line Leader, Editor-in-Chief, Canadian Journal of Urology International and immediate Past President, Society of Urologic Oncology.

Originally from New York, Dr. Gomella completed medical school, general surgery and urology training at the University of Kentucky in Lexington, Kentucky. After a Urologic Oncology Fellowship in the Surgery Branch of the National Cancer Institute in Bethesda, Maryland, he joined the faculty of Jefferson Medical College in 1988 and was appointed Chair in 2002. He is also Associate Director for Clinical Affairs for the Kimmel Cancer at Jefferson and Urology Chair for RTOG, serving as lead Urology investigator on multiple national trials. In 2008 he was named Clinical Director of the Jefferson Kimmel Cancer Center Network.

Dr. Gomella is involved in both basic science and clinical research in the development of new diagnostic techniques and treatments for prostate, bladder and kidney cancer through Jefferson’s Kimmel Cancer Center. Dr. Gomella’s team was first to use RT-PCR to detect micro metastasis in patients with prostate cancer, a discovery that led to a new field of investigation in this disease. Dr. Gomella is also recognized as an early contributor to urologic laparoscopy, initiating the program at Jefferson in 1990.

DR. MATHEW THAKUR

Clinical Collaborator

I am a professor of Radiology and Radiation Oncology at Thomas Jefferson University in Philadelphia. I am also the Director of the laboratories of Radiopharmaceutical research and Molecular Imaging. I obtained my MS and PhD degrees from the University London, England. The major thrust of my research is to develop radiopharmaceuticals for diagnostic and therapeutic applications. I hold 20 granted patents and serve on the editorial board for 14 journals.

My contributions to the field of nuclear medicine and molecular imaging is well recognized by my peers, for which I have received 9 national and International awards, including the Society of Nuclear Medicine’s highest honor, the Benedict Cassen award. I have been elected as President of three international societies, including the Society of Nuclear Medicine and Molecular Imaging. I have been fortunate to have had four of my compounds commercialized and preparations are on the way for two more to be taken into clinical trials. https://sites.google.com/site/mathewthakur/awards

JAY BISHOFF, MD

Clinical Collaborator

Jay Bishoff, MD is the Director of the Intermountain Urological Institute and Director of Robotics. He is a Johns Hopkins fellowship trained surgeon, who serves urology patients, and their families, using best practice guidelines, his measured experience and the least invasive means possible. The training he has received over the past eight years at Intermountain Health Care, has ignited within him a passion for quality improvement and given him a skill set to develop programs that improve patient outcomes, while significantly reducing the cost of health care.

EDOUARD TRABULSI, MD

Clinical Collaborator

Dr. Edouard Trabulsi is a Professor and Vice Chair in the Department of Urology of Sidney Kimmel Medical College at Thomas Jefferson University. He received his Bachelor of Science in Biochemistry cum laude with Distinction in Research from the University of Rochester and completed his medical degree magna cum laude at the State University of New York at Buffalo School of Medicine and Biomedical Sciences. He completed surgery internship, surgery residency, and urology residency at Thomas Jefferson University. He also completed fellowship in urologic oncology and minimally invasive urologic oncology at the Memorial Sloan-Kettering Cancer Center in New York. He specializes in all aspects of urologic oncology and robotic surgery, including prostate cancer, bladder cancer, kidney cancer and testicular cancer. His research interests including advanced imaging for prostate and bladder cancer, including enhanced ultrasound and novel PET imaging, as well as appropriate use of postoperative radiotherapy after radical prostatectomy.
Dr. Trabulsi is Director of the Division of Urologic Oncology in the Department of Urology of Thomas Jefferson University, and Co-Director of the Genitourinary Multidisciplinary Cancer Center at Kimmel Cancer Center and the Jefferson Prostate Diagnostic Center at Thomas Jefferson University. He is the Genitourinary Cancer Multidisciplinary Group Team leader for clinical trials. He previously served as Cancer Liaison Physician for Thomas Jefferson University Hospital for the American College of Surgeons Commission on Cancer. He also has served on several national committees of the American Urologic Association (AUA), including the Education Council, the Resident Core Curriculum Committee and the Legislative Affairs Committee. He is a former President of the Mid-Atlantic Section of the AUA, and just completed service on the Board of Directors for the Society of Urologic Oncology. He is a member of the American Urologic Association, the American College of Surgeons, the American Society of Clinical Oncology, the Society of Urologic Oncology, the American Medical Association, the American Association of Cancer Research and the American College of Health Care Executives.

CHARALAMBOS SOLOMIDES, MD

Clinical Collaborator

Charalambos Solomides, MD is a pathologist in Philadelphia, Pennsylvania with Thomas Jefferson University Hospitals. He received his medical degree from University of Bonn Faculty of Medicine and has been in practice for more than 20 years. Director of Cytopathology at Thomas Jefferson University Hospitals.